# Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis

Study · id `cardio:ct-nct04709770` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04709770](<https://clinicaltrials.gov/study/NCT04709770>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04709770

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 264 participants.

## Technical summary

Registry record NCT04709770. Randomized; single masking; primary purpose treatment. Start 2021-02-01 (anticipated); primary completion 2022-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 264 participants (planned count; ClinicalTrials.gov record NCT04709770, source copy `cardio:ctgov-nct04709770-2021-01-14`, retrieved 2026-10-26)
- Planned start: 2021-02-01 (anticipated) (ClinicalTrials.gov record NCT04709770, source copy `cardio:ctgov-nct04709770-2021-01-14`, retrieved 2026-10-26)
- Primary completion: 2022-03-01 (anticipated) (ClinicalTrials.gov record NCT04709770, source copy `cardio:ctgov-nct04709770-2021-01-14`, retrieved 2026-10-26)
- Completion: 2022-03-01 (anticipated) (ClinicalTrials.gov record NCT04709770, source copy `cardio:ctgov-nct04709770-2021-01-14`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04709770-2021-01-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis
- Acronym: PrepDial
- Condition: Chronic Kidney Diseases
- Condition: Colon Polyp
- Condition: Dialysis; Complications
- Condition: Colon Cancer
- Intervention (Drug): 2-liters polyethylene glycol with citrate and simethicone
- Intervention (Drug): 4-liters polyethylene glycol with simethicone
- Intervention (Dietary supplement): Low-residue diet
- Lead sponsor: Alfredo Di Leo
- Lead sponsor class: OTHER
- Collaborator: Alfasigma S.p.A.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 00c77588e3e8947616db0a7150ff02e4440d3cccbd766ad977b43c70fc89ce9d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
